人体增强市场－全球产业规模、份额、趋势、机会及预测（依技术、设备、应用、区域及竞争格局划分，2021-2031年）

全球人类增强市场预计将从 2025 年的 180.4 亿美元成长到 2031 年的 455.2 亿美元，复合年增长率为 16.68%。

该领域涵盖增强人类认知和身体能力的各种技术，包括神经介面、感觉植入和穿戴式外骨骼。市场加速成长的主要驱动力是重工业对提升工作场所安全性的结构性需求，以及对復健工具的需求，这对全球老化人口至关重要。国际机器人联合会 (IFR) 发布的 2024 年数据显示，全球治疗和辅助医疗机器人的销售量将成长 91%，达到约 16,700 台，这印证了上述成长趋势。这些驱动因素表明，技术辅助性能提升正朝着永久性发展，而非昙花一现的消费潮流。

然而，生物识别资料的隐私和所有权问题引发了复杂的监管和伦理挑战，严重阻碍了市场的广泛扩张。这些设备固有的持续生理监测会带来法律责任，目前尚缺乏统一的全球管治架构。这种监管的不确定性迫使製造商应对不同的合规标准，不可避免地会延缓产品开发週期，并限制跨境商业活动的即时扩充性。

市场驱动因素

义肢和脑机介面（BCI）的技术进步正在从根本上改变整个产业，它们将神经讯号转化为数位指令，并绕过受损的生物路径来恢復运动功能。这项创新满足了庞大人口的迫切需求—根据世界卫生组织（WHO）2024年报告，全球约有13亿人患有严重残疾。临床数据为从研究到商业性化的过程提供了支持。 Synchron公司于2024年9月发布的COMMAND研究结果显示，所有患者在12个月的追踪期内均达到了主要安全性终点，且未发生严重不利事件。这种可靠性对于建立监管机构的信任至关重要，而这种信任是推动这些介面从小众临床试验走向运动障碍标准治疗的关键。

同时，人工智慧 (AI) 与穿戴式装置的快速融合正推动市场成长，使硬体从被动监测工具转变为主动助理。现代 AI 演算法使设备能够即时解读使用者意图和环境状况，从而显着提升听觉和视觉辅助能力。这项技术革新已迅速转化为实际的经济效益。 Meta 公司于 2024 年 10 月发布的 2024 年第三季财报显示，Reality Labs 的营收年增 29% 至 2.7 亿美元，主要得益于 AI 智慧眼镜的强劲表现。这一趋势凸显了车载智慧处理价值创造的关键转折点，显示人类增强正从医疗应用扩展到更广泛的消费领域。

市场挑战

限制全球人类增强市场发展的关键障碍之一是围绕着生物识别资料隐私和所有权的复杂法规环境。随着製造商开发先进的神经介面和外骨骼，他们面临全球框架分散、各司法管辖区合规要求差异巨大的局面。缺乏统一的管治企业将大量资金投入在地化和法律实质审查，而非产品创新。因此，这些整合系统的开发週期漫长，直接阻碍了其在国际市场上的快速商业性化扩张。

此外，资料外洩法律责​​任的不确定性也令机构投资人犹豫不决。生理资料的持续监测使得敏感资讯处理的责任归属不明，从而构成了一道重要的进入门槛。美国医学会 (AMA) 2024 年的一项调查也印证了这种担忧，该调查发现，87% 的医生认为「强有力的资料隐私保障是采用数位医疗和增强智慧工具的先决条件」。主要医疗采用者的这种犹豫不决表明，监管的不确定性正在造成市场规模瓶颈，并阻碍性能增强技术的应用。

市场趋势

工业外骨骼领域向软体机器人的转变，标誌着从笨重僵硬的机械外骨骼向轻便的纤维基主动系统迈出了重要一步。与限制运动范围的传统硬壳外骨骼不同，新一代软体外骨骼采用人工智慧驱动的致动器，提供自适应支撑，旨在减轻物流和製造环境中工人的疲劳。随着企业在不牺牲灵活性的前提下优先考虑人体工学安全性，这种发展趋势正在加速其商业应用。例如，德国Bionic公司开发的「Exia」外骨骼（《机器人报告》2025年5月报告），这些智慧系统利用机器学习技术适应使用者动作，并提供高达38公斤的动态举重辅助，有效减轻高频作业中的肌肉骨骼压力。

同时，人工智慧驱动的仿生义肢及其触觉回馈技术的广泛应用，正在弥合生物感觉与义肢功能之间的鸿沟，从而彻底改变义肢假体产业。製造商正在开发耐用的多点触控手，并具备即时触觉响应功能，与被动式义肢相比，能够感知压力和纹理，从而实现更卓越的运动控制和动觉感知。这项技术的成熟正在推动显着的财务成长；Psyonic公司于2025年4月向美国证券交易委员会（SEC）提交的2024年度报告显示，由于其触觉感测「Ability Hand」的商业化部署，公司收入增长了204%。这一快速成长证实了市场对能够成功将强大的硬体与先进的感测功能相结合的仿生设备的需求日益增长。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球人体增强市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依科技分类​​（穿戴装置、虚拟实境、扩增实境、外骨骼、智慧虚拟助理）
  • 依装置类型（穿戴式、非穿戴式）
  • 依应用领域（医疗、航太与国防、体育与公用事业、媒体与娱乐、教育、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美人体增强市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲人体增强市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区人体增强市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东与非洲人体增强市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章 南美洲人体增强市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球人体增强市场：SWOT分析

第十四章 波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Ekso Bionics Holdings, Inc.
• B-Temia Inc.
• Medtronic plc
• Cyberdyne Inc.
• ReWalk Robotics Ltd.
• Second Sight Medical Products, Inc.
• BrainGate Company
• Hocoma AG
• Raytheon Company
• Samsung Electronics Co., Ltd.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Human Augmentation Market is projected to expand from USD 18.04 Billion in 2025 to USD 45.52 Billion by 2031, registering a CAGR of 16.68%. This sector encompasses technologies intended to boost human cognitive and physical capabilities, including neural interfaces, sensory implants, and wearable exoskeletons. The market's acceleration is primarily fueled by structural needs for enhanced operational safety in heavy industries and essential rehabilitation tools for an aging global population. Evidence of this upward trend is found in 2024 data from the International Federation of Robotics, which reported a 91% increase in global sales of medical robots for therapy and assistance, reaching approximately 16,700 units. These drivers represent a permanent evolution toward technologically assisted performance rather than temporary consumer fads.

However, widespread market expansion is significantly hindered by complex regulatory and ethical hurdles regarding the privacy and ownership of biometric data. The continuous physiological monitoring inherent to these devices introduces legal liabilities that currently lack a unified global governance framework. This regulatory uncertainty compels manufacturers to navigate disjointed compliance standards, which inevitably slows down product development cycles and restricts the immediate scalability of commercial operations across international borders.

Market Driver

Technological advancements in Neuroprosthetics and Brain-Computer Interfaces are fundamentally reshaping the industry by translating neural signals into digital commands, thereby restoring mobility by bypassing damaged biological pathways. This innovation addresses a critical need for a vast demographic, as the World Health Organization reported in 2024 that approximately 1.3 billion people globally suffer from significant disabilities. The progression from research to commercial viability is supported by clinical data; Synchron's September 2024 'COMMAND Study Results' indicated that 100% of patients achieved the primary safety endpoint with no serious adverse events over 12 months. Such reliability is vital for establishing the regulatory confidence necessary to transition these interfaces from niche trials to standard medical treatments for motor impairment.

Simultaneously, the rapid integration of Artificial Intelligence into wearable devices is fueling market growth by evolving hardware from passive monitoring tools into proactive assistants. Modern AI algorithms enable devices to interpret user intent and environmental context in real-time, drastically improving hearing and vision augmentation capabilities. This technological upgrade has generated immediate financial results, as shown in Meta's 'Third Quarter 2024 Results' from October 2024, where Reality Labs revenue grew by 29% year-over-year to $270 million, driven by AI-enabled smart glasses. This trend highlights a decisive shift where value is generated through onboard intelligent processing, extending human augmentation beyond medical use into broad consumer utility.

Market Challenge

The principal obstacle constraining the Global Human Augmentation Market is the intricate regulatory environment concerning biometric data privacy and ownership. As manufacturers engineer advanced neural interfaces and exoskeletons, they face a fragmented global framework where compliance mandates vary drastically across jurisdictions. This absence of unified governance forces companies to redirect significant capital toward localization and legal due diligence rather than product innovation. Consequently, the development timelines for these integrated systems are prolonged, which directly impedes rapid commercial scalability across international markets.

Additionally, the uncertainty surrounding legal liability for data breaches engenders significant hesitation among institutional buyers. The continuous monitoring of physiological data creates undefined accountability regarding the handling of sensitive information, acting as a substantial barrier to entry. This friction is underscored by 2024 findings from the American Medical Association, where 87% of physicians stated that robust data privacy assurances are a prerequisite for adopting digital health and augmented intelligence tools. This reluctance from key medical adopters illustrates how regulatory ambiguity creates a bottleneck in market volume and suppresses the deployment of performance-enhancing technologies.

Market Trends

The shift toward Soft Robotics in industrial exoskeletons represents a major transition from bulky, rigid mechanical suits to lightweight, textile-based active systems. Unlike legacy hard-shell models that limit range of motion, next-generation soft exosuits employ AI-driven actuators to provide adaptive support designed to mitigate worker fatigue in logistics and manufacturing. This evolution is hastening commercial adoption as firms prioritize ergonomic safety without sacrificing agility. As reported by The Robot Report in May 2025 regarding German Bionic's 'Exia' suit, these intelligent systems offer up to 38 kg of dynamic lift assistance while adapting to user movements via machine learning, effectively reducing musculoskeletal strain in high-frequency tasks.

Concurrently, the proliferation of AI-Powered Bionic Limbs with Sensory Feedback is revolutionizing the restorative hardware sector by bridging the gap between biological sensation and prosthetic functionality. Manufacturers are developing durable, multi-touch hands that provide real-time haptic responses, enabling users to perceive pressure and texture for superior motor control and embodiment compared to passive devices. This technological maturity is driving substantial financial growth; Psyonic's April 2025 'Annual Report for Fiscal Year 2024' filed with the SEC noted a 204% increase in revenue attributed to the commercial expansion of its touch-sensing Ability Hand. This surge confirms increasing market demand for bionic devices that successfully combine rugged hardware with advanced sensory capabilities.

Key Market Players

• Ekso Bionics Holdings, Inc.
• B-Temia Inc.
• Medtronic plc
• Cyberdyne Inc.
• ReWalk Robotics Ltd.
• Second Sight Medical Products, Inc.
• BrainGate Company
• Hocoma AG
• Raytheon Company
• Samsung Electronics Co., Ltd.

Report Scope

In this report, the Global Human Augmentation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Human Augmentation Market, By Technology

• Wearable
• Virtual Reality
• Augmented Reality
• Exoskeleton
• Intelligent Virtual Assistant

Human Augmentation Market, By Device

• Body Worn
• Non-Body Worn

Human Augmentation Market, By Application

• Medical
• Aerospace & Defense
• Sports & Utility
• Media & Entertainment
• Education
• Others

Human Augmentation Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Human Augmentation Market.

Available Customizations:

Global Human Augmentation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Human Augmentation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (Wearable, Virtual Reality, Augmented Reality, Exoskeleton, Intelligent Virtual Assistant)
  • 5.2.2. By Device (Body Worn, Non-Body Worn)
  • 5.2.3. By Application (Medical, Aerospace & Defense, Sports & Utility, Media & Entertainment, Education, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Human Augmentation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Device
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Human Augmentation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Device
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Human Augmentation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Device
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Human Augmentation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Device
      • 6.3.3.2.3. By Application

7. Europe Human Augmentation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Device
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Human Augmentation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Device
      • 7.3.1.2.3. By Application
  • 7.3.2. France Human Augmentation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Device
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Human Augmentation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Device
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Human Augmentation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By Device
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Human Augmentation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By Device
      • 7.3.5.2.3. By Application

8. Asia Pacific Human Augmentation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Device
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Human Augmentation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Device
      • 8.3.1.2.3. By Application
  • 8.3.2. India Human Augmentation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Device
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Human Augmentation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Device
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Human Augmentation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By Device
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Human Augmentation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By Device
      • 8.3.5.2.3. By Application

9. Middle East & Africa Human Augmentation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Device
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Human Augmentation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Device
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Human Augmentation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Device
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Human Augmentation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Device
      • 9.3.3.2.3. By Application

10. South America Human Augmentation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By Device
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Human Augmentation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By Device
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Human Augmentation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By Device
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Human Augmentation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By Device
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Human Augmentation Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Ekso Bionics Holdings, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. B-Temia Inc.
• 15.3. Medtronic plc
• 15.4. Cyberdyne Inc.
• 15.5. ReWalk Robotics Ltd.
• 15.6. Second Sight Medical Products, Inc.
• 15.7. BrainGate Company
• 15.8. Hocoma AG
• 15.9. Raytheon Company
• 15.10. Samsung Electronics Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer